cambridge's bluebird bio licenses delivery tech to novartis, gsk
.
.
.
.
latest
. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire.
. severe psoriasis. credit: penn medicine
.